Researchers presented clinical study results on the dual-tracer PET imaging technique at the European urology conference with peer-reviewed publication forthcoming.

Tagawa, MD, identified 3 primary clinical scenarios where PSMA PET scans have become the established standard for prostate cancer care. The first application is initial s ...

But does it cost too much?

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

HIGHLIGHTS ...

A world-first trial of Australian men has confirmed a specialised scan can accurately “light up” prostate cancer, saving unnecessary and painful biopsies and stress of over-diagnosis.

BCUHB patient waited three times longer than he should have for prostate cancer treatment. Delays likely advanced his condition, ombudsman finds.

ASX healthcare stocks remain under pressure, but strong clinical and regulatory catalysts are still driving standout gains across the sector. ... Read More The post Scott Power: Conflict, inflation ...

Delays in treating a patient with an aggressive form of prostate cancer more than likely contributed to his disease advancing ...

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

Prostate cancer screening compares favourably to screening for breast cancer in identifying significant cancers, reducing mortality and avoiding unnecessary harms, says new research. The findings are ...

Betsi Cadwaladr University Health Board’s CEO apologised 'for the unacceptable delays' ...